The extension of the production and specifically the expansion of the evaporative crystallization for pharmaceutical amino acids results in a duplication of the annual production capacity. “This substantial investment sets the foundation for the growing product portfolio for pharmaceutical amino acids that AMINO offers”, explains the managing director Dr. Lutz Thomas. “Innovation and quick transfer into the production scale are the key success factors in the corporate strategy. We have over the past three years more than doubled the number of amino acids and will shortly launch further products to supplement our range”, adds Dr. Thomas.
AMINO GmbH, headquartered in Frellstedt, Germany, is a fully integrated producer of specialty amino acids with natural biological origins. The company is dedicated to producing pharmaceutical-grade and infusion-grade amino acids under strict cGMP standards using the best extraction and purification technology (concentrating on vegetable raw materials) or state-of-the-art biotechnology/fermentation as appropriate.